Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3277916
Max Phase: Preclinical
Molecular Formula: C40H61N11O12S2
Molecular Weight: 952.13
Molecule Type: Small molecule
Associated Items:
ID: ALA3277916
Max Phase: Preclinical
Molecular Formula: C40H61N11O12S2
Molecular Weight: 952.13
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)CCSSC[C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
Standard InChI: InChI=1S/C40H61N11O12S2/c1-5-21(4)34-40(63)48-24(10-11-29(41)53)37(60)49-27(16-30(42)54)38(61)50-28(36(59)45-18-33(57)47-25(14-20(2)3)35(58)44-17-31(43)55)19-65-64-13-12-32(56)46-26(39(62)51-34)15-22-6-8-23(52)9-7-22/h6-9,20-21,24-28,34,52H,5,10-19H2,1-4H3,(H2,41,53)(H2,42,54)(H2,43,55)(H,44,58)(H,45,59)(H,46,56)(H,47,57)(H,48,63)(H,49,60)(H,50,61)(H,51,62)/t21-,24-,25-,26-,27-,28-,34-/m0/s1
Standard InChI Key: BFSFGBPLZATHKC-FNRQIBBHSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 952.13 | Molecular Weight (Monoisotopic): 951.3943 | AlogP: -3.42 | #Rotatable Bonds: 18 |
Polar Surface Area: 382.30 | Molecular Species: NEUTRAL | HBA: 14 | HBD: 12 |
#RO5 Violations: 3 | HBA (Lipinski): 23 | HBD (Lipinski): 15 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.50 | CX Basic pKa: | CX LogP: -4.65 | CX LogD: -4.65 |
Aromatic Rings: 1 | Heavy Atoms: 65 | QED Weighted: 0.06 | Np Likeness Score: 0.60 |
1. Walter R, Smith CW, Roy J, Formento A.. (1976) Oxytocin analogues with combined high smooth muscle and negligible antidiuretic activities. Investigation of position 7 in neurohypophyseal hormones., 19 (6): [PMID:985884] [10.1021/jm00228a017] |
2. Adachi Y, Sakimura K, Shimizu Y, Nakayama M, Terao Y, Yano T, Asami T.. (2017) Potent and selective oxytocin receptor agonists without disulfide bridges., 27 (11): [PMID:28438540] [10.1016/j.bmcl.2017.04.030] |
Source(1):